These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8009071)

  • 1. [Long-term results of the treatment of diffuse systemic scleroderma with interferon-gamma].
    Blétry O; Laraki R; Cabane J; Francès C; Piette JC; Soubrier M; Wechsler B; de Gennes C; Valat C; Cosserat J
    Rev Med Interne; 1993; 14(10):978. PubMed ID: 8009071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic scleroderma. Multicenter trial of 1 year of treatment with recombinant interferon gamma.
    Hunzelmann N; Anders S; Fierlbeck G; Hein R; Herrmann K; Albrecht M; Bell S; Thur J; Muche R; Adelmann-Grill B; Wehner-Caroli J; Gaus W; Krieg T
    Arch Dermatol; 1997 May; 133(5):609-13. PubMed ID: 9158414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of systemic sclerosis with gamma-interferon.
    Hein R; Behr J; Hündgen M; Hunzelmann N; Meurer M; Braun-Falco O; Urbanski A; Krieg T
    Br J Dermatol; 1992 May; 126(5):496-501. PubMed ID: 1610690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant cytokine treatment for scleroderma. Can the antifibrotic potential of interferon-gamma be realized clinically?
    Varga J
    Arch Dermatol; 1997 May; 133(5):637-42. PubMed ID: 9158418
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.
    Vlachoyiannopoulos PG; Tsifetaki N; Dimitriou I; Galaris D; Papiris SA; Moutsopoulos HM
    Ann Rheum Dis; 1996 Oct; 55(10):761-8. PubMed ID: 8984943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant interferon-gamma in the treatment of systemic sclerosis.
    Kahan A; Amor B; Menkes CJ; Strauch G
    Am J Med; 1989 Sep; 87(3):273-7. PubMed ID: 2505614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of progressive scleroderma with gamma-interferon].
    Mensing H
    Hautarzt; 1991 Jun; 42(6):380-3. PubMed ID: 1917461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of severe scleroderma with long-term extracorporeal photopheresis.
    Krasagakis K; Dippel E; Ramaker J; Owsianowski M; Orfanos CE
    Dermatology; 1998; 196(3):309-15. PubMed ID: 9621138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of systemic sclerosis with recombinant interferon-gamma. A phase I/II clinical trial.
    Freundlich B; Jimenez SA; Steen VD; Medsger TA; Szkolnicki M; Jaffe HS
    Arthritis Rheum; 1992 Oct; 35(10):1134-42. PubMed ID: 1418004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with interferon gamma enhances fibrinolysis in systemic sclerosis.
    Gluszko P; Undas A; Kwasny B; Musiał J; Szczeklik A
    Thromb Res; 1998 Aug; 91(4):203-7. PubMed ID: 9736424
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial.
    Grassegger A; Schuler G; Hessenberger G; Walder-Hantich B; Jabkowski J; MacHeiner W; Salmhofer W; Zahel B; Pinter G; Herold M; Klein G; Fritsch PO
    Br J Dermatol; 1998 Oct; 139(4):639-48. PubMed ID: 9892907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
    Polisson RP; Gilkeson GS; Pyun EH; Pisetsky DS; Smith EA; Simon LS
    J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Do the interferons have an antifibrotic action? The internist's point of view].
    Blétry O; Somogyi A
    Rev Med Interne; 2002 Nov; 23 Suppl 4():511s-515s. PubMed ID: 12481407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of interferon-gamma containing gel for local treatment of skin ulcers in autoimmune vasculitides and skin changes in progressive systemic sclerosis.
    Arnaudova P; Rashkov R; Tsanev R
    J Rheumatol; 1993 Aug; 20(8):1445-6. PubMed ID: 8230042
    [No Abstract]   [Full Text] [Related]  

  • 15. Toward rational treatment of scleroderma.
    Freundlich B
    Hosp Pract (Off Ed); 1993 Sep; 28(9A):8, 13-4. PubMed ID: 8408363
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term results in the treatment of metastasizing kidney carcinoma using recombinant alpha-2 or gamma interferon].
    Schneider AW; Otto U; Conrad S; Klosterhalfen H
    Helv Chir Acta; 1990 Nov; 57(3):415-21. PubMed ID: 2125299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis.
    Rose RF; Turner D; Goodfield MJ; Goulden V
    Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):153-5. PubMed ID: 19438995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of diffuse progressive scleroderma.
    EVANS JA; RUBITSKY HJ; PERRY AW
    J Am Med Assoc; 1953 Mar; 151(11):891-9. PubMed ID: 13022338
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic sclerosis.
    Ng SC
    Singapore Med J; 1992 Apr; 33(2):189-92. PubMed ID: 1621127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Presentation and Long-Term Outcomes of Systemic Sclerosis Portuguese Patients from a Single Centre Cohort: A EUSTAR Registration Initiative.
    Vidal C; Ruano C; Bernardino V; Lavado Carreira P; Lladó A; Santos MC; Gruner H; Panarra A; Riso N; Moraes-Fontes MF
    Acta Med Port; 2018 Jun; 31(6):312-320. PubMed ID: 30020876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.